Analysts Set Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Target Price at $50.91

Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Rating) has been assigned an average rating of “Hold” from the eleven research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $50.91.

FSNUY has been the topic of several recent analyst reports. Societe Generale decreased their target price on Fresenius SE & Co. KGaA from €94.00 ($97.92) to €87.00 ($90.63) and set a “buy” rating on the stock in a research note on Friday, February 25th. Berenberg Bank lifted their target price on Fresenius SE & Co. KGaA from €55.95 ($58.28) to €60.25 ($62.76) and gave the company a “buy” rating in a research note on Wednesday, February 16th. HSBC downgraded Fresenius SE & Co. KGaA from a “buy” rating to a “hold” rating in a research note on Tuesday, May 10th. JPMorgan Chase & Co. decreased their target price on Fresenius SE & Co. KGaA from €34.50 ($35.94) to €33.30 ($34.69) and set a “neutral” rating on the stock in a research note on Friday, May 13th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Fresenius SE & Co. KGaA from €38.00 ($39.58) to €36.00 ($37.50) and set a “hold” rating for the company in a report on Friday, February 25th.

Shares of OTCMKTS FSNUY traded up $0.13 during trading on Friday, hitting $8.63. The company had a trading volume of 65,276 shares, compared to its average volume of 119,325. The stock has a 50 day simple moving average of $9.06 and a 200 day simple moving average of $9.65. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.85 and a current ratio of 1.13. Fresenius SE & Co. KGaA has a 12 month low of $7.37 and a 12 month high of $14.81. The firm has a market capitalization of $19.28 billion, a P/E ratio of 8.90 and a beta of 1.24.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Rating) last posted its quarterly earnings data on Tuesday, February 22nd. The company reported $0.27 EPS for the quarter. The firm had revenue of $11.40 billion for the quarter. Fresenius SE & Co. KGaA had a return on equity of 6.73% and a net margin of 4.85%. As a group, analysts predict that Fresenius SE & Co. KGaA will post 0.91 EPS for the current year.

About Fresenius SE & Co. KGaA (Get Rating)

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Read More

Analyst Recommendations for Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.